These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9380086)

  • 1. Granulocyte colony-stimulating factor in afebrile patients with neutropenia.
    Cabanillas F
    N Engl J Med; 1997 Oct; 337(18):1319-20. PubMed ID: 9380086
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
    Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
    Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of granulocyte colony-stimulating factor with dose-intensive chemotherapy.
    Ogawa M
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):7-9. PubMed ID: 7512279
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe neutropenia after renal transplantation and its reversal with granulocyte colony-stimulating factor.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Dec; 26(6):3098-9. PubMed ID: 7527945
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
    Hartmann LC; Tschetter LK; Habermann TM; Ebbert LP; Johnson PS; Mailliard JA; Levitt R; Suman VJ; Witzig TE; Wieand HS; Miller LL; Moertel CG
    N Engl J Med; 1997 Jun; 336(25):1776-80. PubMed ID: 9187067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for the use of granulocyte growth factors].
    Elonen E
    Duodecim; 1997; 113(22):2319-25. PubMed ID: 10892137
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use of colony stimulating factors for established neutropenic fever.
    Walton SM
    W V Med J; 1998; 94(1):26-8. PubMed ID: 9505567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of granulocyte colony-stimulating factor in the treatment of fever and neutropenia in a heart transplant patient.
    Gordon MS; O'Donnell JA; Mohler ER; Cooper MA
    J Heart Lung Transplant; 1993; 12(4):706-7. PubMed ID: 7690254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 11. Study inclusion criteria and presentation of results in a meta-analysis of granulocyte colony-stimulating factor for prevention of febrile neutropenia.
    Lathia N; Isogai PK; Cheung MC; Mittmann N
    J Clin Oncol; 2010 Dec; 28(36):e762-3; author reply e764. PubMed ID: 21079143
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)].
    Schwander S; Kern P
    Med Klin (Munich); 1993 Feb; 88(2):60-2. PubMed ID: 7680750
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum cytokine levels in patients with neutropenia.
    Greendyke RM; Sharma K; Gifford FR
    Arch Pathol Lab Med; 1994 Dec; 118(12):1193-5. PubMed ID: 7526820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
    Jakubowski AA; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla MA; Moore MA; Gabrilove J
    N Engl J Med; 1989 Jan; 320(1):38-42. PubMed ID: 2462670
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hematological effect of 14 days treatment of recombinant human granulocyte colony-stimulating factor for neutropenia in myelodysplastic syndromes].
    Yoshida Y; Hirashima K; Asano S; Takaku F; Furusawa S; Ogawa T; Arimori S; Abe T; Suzuki T; Kato Y
    Rinsho Ketsueki; 1991 Jul; 32(7):743-50. PubMed ID: 1717726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia.
    Cohen AM; Hodak E; David M; Mittelman M; Gal R; Stern R
    Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor, congenital neutropenia, and acute myeloid leukemia.
    Naparstek E
    N Engl J Med; 1995 Aug; 333(8):516-8. PubMed ID: 7542748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.